FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 320:1643-1648 June 22, 1989 Number 25 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Assessment of the risks of transmission of infection with human immunodeficiency virus type 1 (HIV-1) from mother to newborn is difficult, partly because of the persistence for up to a year of maternal antibodies transmitted passively to the infant. To determine the frequency of perinatal transmission of HIV infection, we studied from birth 308 infants born to seropositive women, 62 percent of whom were intravenous drug abusers. Of 117 infants evaluated 18 months after birth, 32 (27 percent) were seropositive for HIV or had died of the acquired immunodeficiency syndrome (AIDS) (n = 6); of the 32, only 2 remained asymptomatic. Another 76 infants (65 percent) were seronegative and free of symptoms, whereas 9 (8 percent) were seronegative but had symptoms suggestive of HIV-1 infection. The infants infected with HIV-1 did not differ from the others at birth with respect to weight, height, head circumference, or rate of malformations, but as compared with newborns who were seronegative at 18 months, their serum IgM levels were higher (78 +/- 81 mg per deciliter vs. 38 +/- 39 mg per deciliter; P less than 0.03) and their CD4 lymphocyte counts were lower (2054 +/- 1221 per cubic millimeter vs. 2901 +/- 1195 per cubic millimeter; P less than 0.006). Neither maternal risk factors nor the route of delivery was a predictor of seropositivity at 18 months; however, 5 of the 6 infants who were breast-fed became seropositive, as compared with 25 of 99 who were not (P less than 0.01). We conclude that approximately one third of the infants born to seropositive mothers will have evidence of HIV-1 infection or of AIDS by the age of 18 months, and that about one fifth of this group will have died.

Source Information

Immunology and Hematology Unit, Hopital Necker, Paris, France.

This article has been cited by other articles:

• Post, M. J. D. (2005). A New Challenge for the Neuroradiologist: MR Recognition of Mitochondrial Dysfunction in Children Born of HIV-Seropositive Mothers on Antiretroviral Therapy. Am. J. Neuroradiol. 26: 687-689 [Full Text]  
• Tardieu, M., Brunelle, F., Raybaud, C., Ball, W., Barret, B., Pautard, B., Lachassine, E., Mayaux, M.-J., Blanche, S. (2005). Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine. Am. J. Neuroradiol. 26: 695-701 [Abstract] [Full Text]  
• Read, J. S., Committee on Pediatric AIDS, (2003). Human Milk, Breastfeeding, and Transmission of Human Immunodeficiency Virus Type 1 in the United States. Pediatrics 112: 1196-1205 [Abstract] [Full Text]  
• Vidricaire, G., Tardif, M. R., Tremblay, M. J. (2003). The Low Viral Production in Trophoblastic Cells Is Due to a High Endocytic Internalization of the Human Immunodeficiency Virus Type 1 and Can Be Overcome by the Pro-inflammatory Cytokines Tumor Necrosis Factor-alpha and Interleukin-1. J. Biol. Chem. 278: 15832-15841 [Abstract] [Full Text]  
• Dreyfuss, M. L, Msamanga, G. I, Spiegelman, D., Hunter, D. J, Urassa, E. J., Hertzmark, E., Fawzi, W. W (2001). Determinants of low birth weight among HIV-infected pregnant women in Tanzania. Am. J. Clin. Nutr. 74: 814-826 [Abstract] [Full Text]  
• Rongkavilit, C., Thaithumyanon, P., Chuenyam, T., Damle, B. D., Limpongsanurak, S., Boonrod, C., Srigritsanapol, A., Hassink, E. A. M., Hoetelmans, R. M. W., Cooper, D. A., Lange, J. M. A., Ruxrungtham, K., Phanuphak, P. (2001). Pharmacokinetics of Stavudine and Didanosine Coadministered with Nelfinavir in Human Immunodeficiency Virus-Exposed Neonates. Antimicrob. Agents Chemother. 45: 3585-3590 [Abstract] [Full Text]  
• (2001). Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial. Arch. Dis. Child. 84: 230-236 [Abstract] [Full Text]  
• Teglas, J.-P., Mayaux, M.-J., Blanche, S., Pezzotti, P., Rezza, G., Balducci, M., Tovo, P.-A., Gabiano, C., Galli, L., de Martino, M. (2000). Antiretroviral Therapy and Mortality Among Children With Perinatal HIV Infection. JAMA 284: 2871-2872 [Full Text]  
• Zeichner, S. L., Palumbo, P., Feng, Y., Xiao, X., Gee, D., Sleasman, J., Goodenow, M., Biggar, R., Dimitrov, D. (1999). Rapid Telomere Shortening in Children. Blood 93: 2824-2830 [Abstract] [Full Text]  
• van Rompay, K. K. A., Dailey, P. J., Tarara, R. P., Canfield, D. R., Aguirre, N. L., Cherrington, J. M., Lamy, P. D., Bischofberger, N., Pedersen, N. C., Marthas, M. L. (1999). Early Short-Term 9-[2-(R)-(Phosphonomethoxy)Propyl]Adenine Treatment Favorably Alters the Subsequent Disease Course in Simian Immunodeficiency Virus-Infected Newborn Rhesus Macaques. J. Virol. 73: 2947-2955 [Abstract] [Full Text]  
• Sharma, U. K., Trujillo, J., Song, H.-F., Saitta, F. P., Laeyendecker, O. B., Castillo, R., Arango-Jaramillo, S., Sridharan, G., Dettenhofer, M., Blakemore, K., Yu, X.-F., Schwartz, D. H. (1998). A Novel Factor Produced by Placental Cells with Activity Against HIV-1. J. Immunol. 161: 6406-6412 [Abstract] [Full Text]  
• Weng, S., Bulterys, M., Chao, A., Stidley, C. A., Dushimimana, A., Mbarutso, E., Saah, A. (1998). Perinatal Human Immunodeficiency Virus-1 Transmission and Intrauterine Growth: A Cohort Study in Butare, Rwanda. Pediatrics 102: e24-24 [Abstract] [Full Text]  
• Mandelbrot, L., Le Chenadec, J., Berrebi, A., Bongain, A., Benifla, J.-L., Delfraissy, J.-F., Blanche, S., Mayaux, M.-J., for the French Perinatal Cohort, (1998). Perinatal HIV-1 Transmission: Interaction Between Zidovudine Prophylaxis and Mode of Delivery in the French Perinatal Cohort. JAMA 280: 55-60 [Abstract] [Full Text]  
• Owens, D. K., Brandeau, M. L., Sox, C. H. (1998). Effect of Relapse to High-Risk Behavior on the Costs and Benefits of a Program to Screen Women for Human Immunodeficiency Virus. Interfaces 28: 52-74 [Abstract]  
• Yedavalli, V. R. K., Chappey, C., Matala, E., Ahmad, N. (1998). Conservation of an Intact vif Gene of Human Immunodeficiency Virus Type 1 during Maternal-Fetal Transmission. J. Virol. 72: 1092-1102 [Abstract] [Full Text]  
• Patterson, T. A., Binienda, Z. K., Lipe, G. W., Gillam, M. P., Slikker, W. Jr., Sandberg, J. A. (1997). Transplacental Pharmacokinetics and Fetal Distribution of Azidothymidine, Its Glucuronide, and Phosphorylated Metabolites in Late-Term Rhesus Macaques after Maternal Infusion. Drug Metab. Dispos. 25: 453-459 [Abstract] [Full Text]  
• Blanche, S., Mayaux, M.-J., Rouzioux, C., Teglas, J.-P., Firtion, G., Monpoux, F., Cicaru-Vigneron, N., Meier, F., Tricoire, J., Courpotin, C., Vilmer, E., Griscelli, C., Delfraissy, J.-F., The French Pediatric HIV Infection Study Group, (1994). Relation of the Course of HIV Infection in Children to the Severity of the Disease in Their Mothers at Delivery. NEJM 330: 308-312 [Abstract] [Full Text]  
• Chamberlain, M. C. (1993). Pediatric AIDS: A Longitudinal Comparative MRI and CT Brain Imaging Study. J Child Neurol 8: 175-181 [Abstract]  
• Odebiyi, A.I. (1993). Sex-role patterns: implications for AIDS in children. Childhood 1: 38-45 [Abstract]  
• BAUMEISTER, A. A., KUPSTAS, F. D., KLINDWORTH, L. M. (1991). The New Morbidity: A National Plan of Action. American Behavioral Scientist 34: 468-500  
• (1989). HIV TRANSMISSION TO NEWBORNS. JWatch General 1989: 6-6 [Full Text]